Souri, Z.; Wierenga, A.P.A.; Kroes, W.G.M.; van der Velden, P.A.; Verdijk, R.M.; Eikmans, M.; Luyten, G.P.M.; Jager, M.J.
LAG3 and Its Ligands Show Increased Expression in High-Risk Uveal Melanoma. Cancers 2021, 13, 4445.
https://doi.org/10.3390/cancers13174445
AMA Style
Souri Z, Wierenga APA, Kroes WGM, van der Velden PA, Verdijk RM, Eikmans M, Luyten GPM, Jager MJ.
LAG3 and Its Ligands Show Increased Expression in High-Risk Uveal Melanoma. Cancers. 2021; 13(17):4445.
https://doi.org/10.3390/cancers13174445
Chicago/Turabian Style
Souri, Zahra, Annemijn P. A. Wierenga, Wilma G. M. Kroes, Pieter A. van der Velden, Robert M. Verdijk, Michael Eikmans, Gregorius P. M. Luyten, and Martine J. Jager.
2021. "LAG3 and Its Ligands Show Increased Expression in High-Risk Uveal Melanoma" Cancers 13, no. 17: 4445.
https://doi.org/10.3390/cancers13174445
APA Style
Souri, Z., Wierenga, A. P. A., Kroes, W. G. M., van der Velden, P. A., Verdijk, R. M., Eikmans, M., Luyten, G. P. M., & Jager, M. J.
(2021). LAG3 and Its Ligands Show Increased Expression in High-Risk Uveal Melanoma. Cancers, 13(17), 4445.
https://doi.org/10.3390/cancers13174445